OBJECTIVE: A longitudinal focus on gene-environment vulnerability and resilience in both patients, their unaffected family members and non-related controls offers the opportunity to elucidate etiological and pathogenetic factors influencing the onset and course of psychotic disorders. The current paper delineates the objectives, sample characteristics, recruitment and assessment procedures of the Genetic Risk and Outcome of Psychoses (GROUP) study. METHODS: A naturalistic longitudinal cohort study with assessments at baseline, after three and six years of follow-up. The study is conducted by a consortium of four university psychiatric centres, with their affiliated mental health care institutions in the Netherlands covering more than 7.5 million inhabitants. Extensive assessment of genetic factors, environmental factors, (endo)phenotypes, and outcome. RESULTS: At baseline, 1120 patients, 1057 siblings, 919 parents and 590 healthy controls were included. CONCLUSION: The GROUP study will contribute to insight in risk and protective factors in the aetiology of non-affective psychotic disorders, and in the variation in their course and outcome.
RCT Entities:
OBJECTIVE: A longitudinal focus on gene-environment vulnerability and resilience in both patients, their unaffected family members and non-related controls offers the opportunity to elucidate etiological and pathogenetic factors influencing the onset and course of psychotic disorders. The current paper delineates the objectives, sample characteristics, recruitment and assessment procedures of the Genetic Risk and Outcome of Psychoses (GROUP) study. METHODS: A naturalistic longitudinal cohort study with assessments at baseline, after three and six years of follow-up. The study is conducted by a consortium of four university psychiatric centres, with their affiliated mental health care institutions in the Netherlands covering more than 7.5 million inhabitants. Extensive assessment of genetic factors, environmental factors, (endo)phenotypes, and outcome. RESULTS: At baseline, 1120 patients, 1057 siblings, 919 parents and 590 healthy controls were included. CONCLUSION: The GROUP study will contribute to insight in risk and protective factors in the aetiology of non-affective psychotic disorders, and in the variation in their course and outcome.
Authors: Jussi Hirvonen; Theo G M van Erp; Jukka Huttunen; Sargo Aalto; Kjell Någren; Matti Huttunen; Jouko Lönnqvist; Jaakko Kaprio; Jarmo Hietala; Tyrone D Cannon Journal: Arch Gen Psychiatry Date: 2005-04
Authors: Adela-Maria Isvoranu; Claudia D van Borkulo; Lindy-Lou Boyette; Johanna T W Wigman; Christiaan H Vinkers; Denny Borsboom Journal: Schizophr Bull Date: 2016-05-10 Impact factor: 9.306
Authors: C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker Journal: Neuroscience Date: 2013-01-05 Impact factor: 3.590
Authors: Jorien van der Velde; Paula M Gromann; Marte Swart; Durk Wiersma; Lieuwe de Haan; Richard Bruggeman; Lydia Krabbendam; André Aleman Journal: Soc Cogn Affect Neurosci Date: 2014-04-23 Impact factor: 3.436
Authors: Suzanne Medema; Roel J T Mocking; Maarten W J Koeter; Frédéric M Vaz; Carin Meijer; Lieuwe de Haan; Nico J M van Beveren; René Kahn; Lieuwe de Haan; Jim van Os; Durk Wiersma; Richard Bruggeman; Wiepke Cahn; Carin Meijer; Inez Myin-Germeys Journal: Schizophr Bull Date: 2015-09-18 Impact factor: 9.306
Authors: Sinan Guloksuz; Lotta-Katrin Pries; Philippe Delespaul; Gunter Kenis; Jurjen J Luykx; Bochao D Lin; Alexander L Richards; Berna Akdede; Tolga Binbay; Vesile Altınyazar; Berna Yalınçetin; Güvem Gümüş-Akay; Burçin Cihan; Haldun Soygür; Halis Ulaş; EylemŞahin Cankurtaran; Semra Ulusoy Kaymak; Marina M Mihaljevic; Sanja Andric Petrovic; Tijana Mirjanic; Miguel Bernardo; Bibiana Cabrera; Julio Bobes; Pilar A Saiz; María Paz García-Portilla; Julio Sanjuan; Eduardo J Aguilar; José Luis Santos; Estela Jiménez-López; Manuel Arrojo; Angel Carracedo; Gonzalo López; Javier González-Peñas; Mara Parellada; Nadja P Maric; Cem Atbaşog Lu; Alp Ucok; Köksal Alptekin; Meram Can Saka; Celso Arango; Michael O'Donovan; Bart P F Rutten; Jim van Os Journal: World Psychiatry Date: 2019-06 Impact factor: 49.548
Authors: Jorien van der Velde; Paula M Gromann; Marte Swart; Lieuwe de Haan; Durk Wiersma; Richard Bruggeman; Lydia Krabbendam; André Aleman Journal: J Psychiatry Neurosci Date: 2015-05 Impact factor: 6.186
Authors: D S van Dam; N Korver-Nieberg; E Velthorst; C J Meijer; L de Haan Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2014-06-17 Impact factor: 4.328